argenx

Driving innovation in autoimmune disease treatment begins with deepening our understanding of conditions through meaningful connections with the patient community. Bilal's journey with thyroid eye disease (TED) highlights the value of patient?insights in advancing care and research. To learn more about Bilal's experience, read his story below??? #TogetherWeDiscover

We’re excited to announce a partnership with?Steritas to advance the evidence supporting novel steroid-sparing therapeutics across our immunology development programs.? ? We look forward to collaborating with Steritas to support the development of innovative steroid-sparing treatments for autoimmune diseases. Learn more:?https://bit.ly/4eMvvqG ? #TogetherWeDiscover?

Today we announced the decision to continue the ongoing Phase 2/3 ALKIVIA study in adults with idiopathic inflammatory myopathies (IIM or myositis) in each of the three myositis subtypes.? ? We are advancing our understanding of the pathophysiology of myositis, further establishing the causal role of IgG antibodies in the disease. Precision therapies now take this understanding one step further.? ? Learn more: https://bit.ly/4eKfiCd ? #TogetherWeDiscover?

At argenx, embracing a growth mindset drives both career advancement and patient impact. Our colleagues share how their motivation to seize professional growth opportunities stems from their passion for supporting patients. How has adopting a growth mindset helped you make a positive impact on patient care? Share below ?? #TogetherWeDiscover

Our Immunology Innovation Program (IIP) allows us to partner with leaders in disease biology. Associate Director of Strategic Alliances?Ruani Fernando harnesses her passion for collaboration into identifying IIP partners with transformative scientific discoveries. Discover more about the IIP and our partners:?https://bit.ly/3O4eOw9 #TogetherWeDiscover?

We’re proud to join?Making The Most of Now and?Clive Phillips to raise awareness of multifocal motor neuropathy (MMN) through the Tour de MMN in 2025. The Tour de MMN raises awareness and funding for MMN research by GBS|CIDP Foundation International through a cycling ride across France. It’s an honor to support this initiative to bring hope, support, and resources to the MMN community. #TogetherWeDiscover #TourdeMMN?

At argenx, innovation is at the center of our work to transform scientific discovery into transformative treatments. We're proud of the progress we've made thus far and remain committed to expanding our global patient reach. #TogetherWeDiscover

More than 65 million people in the U.S.?provide care for a family member during any given year. Tony, a myasthenia gravis (MG) patient, and his wife Catherine highlight the immeasurable difference caregivers make in their loved ones’ journey.? ? This #NationalFamilyCaregiversMonth, we want to celebrate and thank family caregivers for all they do for those they support. Their unwavering dedication is truly inspiring.? ? #TogetherWeDiscover?

Our third-quarter earnings report is now available. This quarter we: ???Increased our patient impact, expanding our gMG footprint and delivering innovation to CIDP patients ???Advanced Vision 2030, investing in our continuous pipeline of differentiated antibody candidates, with the goal of reaching 50,000 patients and 10 labeled indications by 2030 ???Further invested in our Immunology Innovation Program (IIP) with the nomination of four new pipeline candidates to drive long-term, sustainable growth Read the full Q3 earnings report: https://bit.ly/4f76Zl0 #TogetherWeDiscover

As a key focus of our presentations at this year’s?American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting, we highlighted the significance of minimal symptom expression (MSE) as a key treatment goal for myasthenia gravis (MG). ? When disease management strategies work well, they not only help control the condition but also make a positive difference in patients’ lives. Achieving MSE indicates that these strategies are having a meaningful impact.? ? Learn more about our commitment to the MG patient community to help them reach MSE: https://bit.ly/4fnaofk ? #TogetherWeDiscover?